Amyloidosis
IRB #H-22603/SCT #0156: Phase II Trial of Second Autologous Transplantation in AL Amyloidosis
IRB #H-22393/SWOG #S0115: A Phase II Trial Evaluating Modified HD Melphalan (100 mg/m2) and Auto SCT for patients with AL Amyloidosis, Light Chain Deposition Disease or High Risk Patients with MM
IRB #H-26320: Phase II Trial of MRD (Melphalan, Lenalidomide and Dexamethasone) for Patients with AL Amyloidosis
IRB #H-27288/Karmanos: A Multicenter Phase II Trial of Bortezomib (Velcade), Melphalan, and Dexamethasone (V-MD) in Patients with Symptomatic AL-Amyloidosis or Light Chain Deposition Disease
IRB #H-28441/X50292: Phase II Trial of Induction Therapy with Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation in Patients with AL Amyloidosis
